Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis

Inclusion Criteria: * Diagnosis of invasive candidiasis defined as a positive culture of blood or from another normally sterile site for Candida. * Not of reproductive potential or if of reproductive potential, agrees to remain abstinent or use 2 methods of contraception. Exclusion Criteria: * Patient with Candida endocarditis, osteomyelitis, meningitis, or chronic disseminated candidiasis or evidence of endophthalmitis. * Patient has failed treatment with an echinocandin for this episode of invasive candidiasis. * Infection limited to the oropharynx, esophagus, urogenital system, or skin, or sputum/bronchoalveolar lavage culture. * Participation in a clinical study with other investigational drug(s) within 30 days prior to study entry or during this study.